Compare CRDF & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDF | ACU |
|---|---|---|
| Founded | 1999 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 154.0M |
| IPO Year | N/A | N/A |
| Metric | CRDF | ACU |
|---|---|---|
| Price | $2.93 | $41.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.63 | N/A |
| AVG Volume (30 Days) | ★ 914.5K | 8.5K |
| Earning Date | 11-06-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.45 |
| Revenue | $501,000.00 | ★ $194,960,991.00 |
| Revenue This Year | N/A | $3.05 |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | ★ N/A | $17.29 |
| Revenue Growth | N/A | ★ 2.35 |
| 52 Week Low | $1.90 | $34.35 |
| 52 Week High | $5.00 | $45.25 |
| Indicator | CRDF | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 76.82 | 65.88 |
| Support Level | $2.32 | $35.61 |
| Resistance Level | $2.59 | $42.74 |
| Average True Range (ATR) | 0.15 | 1.32 |
| MACD | 0.05 | 0.51 |
| Stochastic Oscillator | 99.34 | 83.45 |
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.